A detailed history of Wedbush Securities Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Wedbush Securities Inc holds 87,245 shares of NVO stock, worth $9.42 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
87,245
Previous 100,827 13.47%
Holding current value
$9.42 Million
Previous $14.4 Million 27.82%
% of portfolio
0.39%
Previous 0.51%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$119.07 - $145.42 $1.62 Million - $1.98 Million
-13,582 Reduced 13.47%
87,245 $10.4 Million
Q2 2024

Aug 06, 2024

BUY
$122.71 - $146.91 $181,733 - $217,573
1,481 Added 1.49%
100,827 $14.4 Million
Q1 2024

May 14, 2024

BUY
$102.11 - $135.92 $942,066 - $1.25 Million
9,226 Added 10.24%
99,346 $12.8 Million
Q4 2023

Feb 12, 2024

BUY
$87.78 - $105.45 $310,653 - $373,187
3,539 Added 4.09%
90,120 $9.32 Million
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $4.12 Million - $9.05 Million
45,348 Added 109.98%
86,581 $7.87 Million
Q2 2023

Aug 14, 2023

SELL
$155.98 - $172.65 $331,301 - $366,708
-2,124 Reduced 4.9%
41,233 $6.67 Million
Q1 2023

May 09, 2023

BUY
$132.34 - $159.14 $5.37 Million - $6.46 Million
40,562 Added 1451.23%
43,357 $6.9 Million
Q4 2022

Jan 31, 2023

SELL
$102.55 - $135.33 $3.72 Million - $4.91 Million
-36,309 Reduced 92.85%
2,795 $378,000
Q3 2022

Oct 18, 2022

SELL
$95.28 - $116.93 $46,877 - $57,529
-492 Reduced 1.24%
39,104 $3.9 Million
Q2 2022

Jul 21, 2022

SELL
$103.24 - $121.81 $14,969 - $17,662
-145 Reduced 0.36%
39,596 $4.41 Million
Q1 2022

Apr 19, 2022

SELL
$93.1 - $112.54 $21,692 - $26,221
-233 Reduced 0.58%
39,741 $4.41 Million
Q4 2021

Jan 13, 2022

BUY
$95.88 - $117.08 $68,554 - $83,712
715 Added 1.82%
39,974 $4.48 Million
Q3 2021

Oct 08, 2021

SELL
$84.42 - $106.62 $38,917 - $49,151
-461 Reduced 1.16%
39,259 $3.77 Million
Q2 2021

Jul 27, 2021

BUY
$67.66 - $84.76 $45,332 - $56,789
670 Added 1.72%
39,720 $3.33 Million
Q1 2021

Apr 26, 2021

BUY
$67.06 - $75.82 $51,099 - $57,774
762 Added 1.99%
39,050 $2.63 Million
Q3 2020

Oct 20, 2020

SELL
$63.69 - $70.22 $15,922 - $17,555
-250 Reduced 0.65%
38,288 $2.66 Million
Q2 2020

Jul 16, 2020

SELL
$58.54 - $67.94 $6,673 - $7,745
-114 Reduced 0.29%
38,538 $2.52 Million
Q1 2020

Apr 17, 2020

SELL
$49.46 - $64.78 $11,425 - $14,964
-231 Reduced 0.59%
38,652 $2.33 Million
Q3 2019

Oct 17, 2019

BUY
$47.54 - $53.43 $18,397 - $20,677
387 Added 1.01%
38,883 $2.01 Million
Q2 2019

Aug 01, 2019

SELL
$46.79 - $52.47 $20,774 - $23,296
-444 Reduced 1.14%
38,496 $1.97 Million
Q1 2019

Apr 17, 2019

SELL
$46.36 - $52.63 $5,795 - $6,578
-125 Reduced 0.32%
38,940 $2.04 Million
Q4 2018

Jan 31, 2019

BUY
$41.54 - $47.25 $5,732 - $6,520
138 Added 0.35%
39,065 $1.8 Million
Q3 2018

Nov 13, 2018

SELL
$46.76 - $51.24 $11,877 - $13,014
-254 Reduced 0.65%
38,927 $1.84 Million
Q2 2018

Aug 03, 2018

BUY
$44.29 - $50.42 $55,495 - $63,176
1,253 Added 3.3%
39,181 $1.81 Million
Q1 2018

May 01, 2018

BUY
$48.49 - $58.14 $15,080 - $18,081
311 Added 0.83%
37,928 $1.87 Million
Q3 2017

Oct 31, 2017

BUY
$41.15 - $49.22 $1.55 Million - $1.85 Million
37,617
37,617 $1.81 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $244B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Wedbush Securities Inc Portfolio

Follow Wedbush Securities Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wedbush Securities Inc with notifications on news.